Authors:
APPEL S
LEMARECHAL MO
KUMLE A
HUBERT M
LEGANGNEUX E
Citation: S. Appel et al., SIMULTANEOUS PO AND IV PHARMACOKINETIC MODELING OF THE NOVEL SELECTIVE 5-HT4 RECEPTOR AGONIST SDZ HTF-919 IN HUMANS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 85-85
Authors:
MACRO M
BOUVARD G
LEGANGNEUX E
COLIN T
LOYAU G
Citation: M. Macro et al., INTRAVENOUS AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE DOES NOT MODIFY TC-99M-HYDROXYMETHYLENE BISPHOSPHONATE BONE-SCINTIGRAPHY - A PROSPECTIVE-STUDY, Revue du rhumatisme, 62(2), 1995, pp. 99-104
Authors:
MACRO M
LEGANGNEUX E
GALLET E
MARAGNES P
GALATEAU F
LOYAU G
Citation: M. Macro et al., SEVERE LUPUS WITH INFECTIOUS THYROIDITIS AND LETHAL CARDIOMYOPATHY, Clinical and experimental rheumatology, 13(1), 1995, pp. 99-102
Authors:
LEGANGNEUX E
MORA JJ
THORIN I
SPREUXVAROQUAUX O
HERROU M
Citation: E. Legangneux et al., EXPLORATION OF SEROTONIN FUNCTION IN THE PRIMARY FIBROMYALGIA SYNDROME (PFS), Arthritis and rheumatism, 38(9), 1995, pp. 570-570
Authors:
SEDILLO P
RIOUX P
LEGANGNEUX E
THORIN I
SEGONZAC A
ZARIFIAN E
Citation: P. Sedillo et al., CLINICAL-TRIALS AND GOOD CLINICAL-PRACTIC E - RESULTS OF A TELEPHONE SURVEY AMONG 867 DOCTORS IN WESTERN NORMANDY, Therapie, 48(3), 1993, pp. 243-248